Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CTLA4 antibody (Biotin)

The Mouse Monoclonal anti-CTLA4 antibody has been validated for FACS. It is suitable to detect CTLA4 in samples from Human. There are 4+ publications available.
Catalog No. ABIN2688990

Quick Overview for CTLA4 antibody (Biotin) (ABIN2688990)

Target

See all CTLA4 Antibodies
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Reactivity

  • 148
  • 77
  • 45
  • 14
  • 3
Human

Host

  • 86
  • 80
  • 17
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Mouse

Clonality

  • 118
  • 72
  • 3
Monoclonal

Conjugate

  • 105
  • 16
  • 13
  • 11
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CTLA4 antibody is conjugated to Biotin

Application

  • 90
  • 90
  • 63
  • 57
  • 43
  • 36
  • 19
  • 13
  • 10
  • 7
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
Flow Cytometry (FACS)

Clone

BNI3
  • Brand

    BD Pharmingen™

    Characteristics

    Reacts with the "cytolytic T lymphocyte-associated antigen", CTLA-4. CTLA-4 is transiently expressed on activated CD28+ T cells and binds to CD80 and CD86 present on antigen presenting cells (APC) with high avidity. This interaction appears to deliver a negative regulatory signal to the T cell. There are recent reports that indicate that CTLA-4 is also expressed on B cells when cultured with activated T cells, suggesting a possible role of CTLA-4 in the regulation of B-cell response. Immobilized BNI3.1 enhances T-cell proliferation induced by CD3 and CD28. This antibody is routinely tested by flow cytometric analysis. Other applications were tested during antibody development only or reported in the literature. Profile of Concanavalin A-stimulated peripheral blood mononuclear cells analyzed on a FACScan

    BD Pharmingen™ Biotin Mouse Anti-Human CD152 - Biotin - Clone BNI3 - Isotype Mouse IgG2a, κ - Reactivity Hu - 100 Tests

    Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Isotype

    IgG2a kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Sample Volume

    20 μL

    Restrictions

    For Research Use only
  • Buffer

    Aqueous buffered solution containing BSA and ≤0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.

    Storage

    4 °C

    Storage Comment

    Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
  • Morton, Fu, Stewart, Giacoletto, White, Leysath, Evans, Shieh, Karr: "Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2)." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 156, Issue 3, pp. 1047-54, (1996) (PubMed).

    Kuiper, Brouwer, Linsley, van Lier: "Activated T cells can induce high levels of CTLA-4 expression on B cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 155, Issue 4, pp. 1776-83, (1995) (PubMed).

    Lindsten, Lee, Harris, Petryniak, Craighead, Reynolds, Lombard, Freeman, Nadler, Gray: "Characterization of CTLA-4 structure and expression on human T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 151, Issue 7, pp. 3489-99, (1993) (PubMed).

    Guesdon, Ternynck, Avrameas: "The use of avidin-biotin interaction in immunoenzymatic techniques." in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 27, Issue 8, pp. 1131-9, (1979) (PubMed).

  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Alternative Name

    CD152

    Background

    Synonyms: CTLA-4

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!